23.02.2013 Views

LabAutomation 2006 - SLAS

LabAutomation 2006 - SLAS

LabAutomation 2006 - SLAS

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TP03<br />

Donat Elsener<br />

REMP AG<br />

CH-3672 Oberdiessbach,<br />

Switzerland<br />

donat.elsener@remp.com<br />

Where Laboratory Technologies Emerge and Merge<br />

Co-Author<br />

Michael Girardi<br />

REMP<br />

Centralized vs. Multi-Site Compound Management<br />

The cost of drug development has soared over the last decades, as well as, the efforts into sales and marketing of the end-product drugs.<br />

Companies realize that the larger they are the easier it is to bare large investments and leverage their marketing activities. In order to<br />

maximize return-on-investment, the companies are engaging in continuous merging activities. Life Science Research companies, nowadays,<br />

consist of multiple R&D sites distributed all around the world. Individual sites often work on dedicated targets or on specific therapeutic areas<br />

with synergies generated through access to each others research results. In order to maximize global research effectiveness, all research<br />

scientists need an overview and physical access to the entire compound collection of independently built up libraries.<br />

TP04<br />

Nancy Elser<br />

Eksigent Technologies<br />

Dublin, California<br />

nelser@eksigent.com<br />

Co-Author(s)<br />

Ring-Ling Chien<br />

David Rakestraw<br />

Eksigent Technologies<br />

David Emlyn Hughes<br />

Chromatographic Excellence<br />

Method Development of Liquid Chromatographic Procedures for Pharmaceutical<br />

and Biotechnological Entities by Use of the ExpressLC-800 Multi-channel Capillary<br />

LC System<br />

Liquid chromatographic (LC) development of methods for conventional and proteineous drug analysis is a time-consuming but critical<br />

task. Development of a method without sufficient experimentation to produce optimized selectivity often causes significant problems at<br />

some time in the drug development cycle. A method development chemist would ideally study a number of column stationary and mobile<br />

phase conditions and choose the stationary/mobile phase combination that optimizes both resolution of important species and method<br />

robustness. Such an extensive study with conventional LC is often impractical, since investigating multiple chromatographic conditions<br />

requires time-consuming column exchanges and re-equilibrations. Computer-assisted column switching requires extensive re-equilibration<br />

times and often produces unreliable results. Multi-channel capillary LC method development will be shown to generate an extensive set of<br />

chromatograms whereby determination of the most selective separatory conditions can be made. In this presentation, a capillary LC with<br />

eight independent channels (the ExpressLC-800) will be used to produce sample separations with eight columns, four pH conditions and<br />

optimized gradient endpoints; typically, within four hours. The instrument provides method development data quickly by performing eight<br />

separations simultaneously on a capillary LC system that produces high-resolution separations and requires very short re-equilibration times.<br />

153

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!